( NASDAQ-SMALL:ROSG )

News from rosetta genomics ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 31, 2007, 01:00 ET Rosetta Genomics is Issued Another Patent Relating to MicroRNAs

REHOVOT, Israel and NEW YORK, July 31 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a global leader in the field of microRNA...


Jul 31, 2007, 01:00 ET Rosetta Genomics is Issued Another Patent Relating to MicroRNAs

REHOVOT, Israel and NEW YORK, July 31 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a global leader in the field of microRNA...


Jul 05, 2007, 01:00 ET Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression

/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq:ROSG), a leading microRNA company, announced today research published in the journal...


Jul 03, 2007, 01:00 ET Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference

/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq:ROSG), a leading microRNA company, announced today that J. Michael French, Rosetta...


May 21, 2007, 01:00 ET Rosetta Genomics Signs Research Agreement With Columbia University Medical Center to Advance its Lead Cancer Diagnostics Program

/PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG), a leading microRNA company, announced today it has signed a research agreement with...


May 15, 2007, 01:00 ET Rosetta Genomics Receives First Ever Patent Supporting MicroRNA-Based Diagnostics and Therapeutics

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading microRNA company, announced today that on May 15, 2007, the United...


May 08, 2007, 01:00 ET Rosetta Genomics, a Leader in MicroRNA-based Diagnostics and Therapeutics Announces First Quarter 2007 Financial Results; Liver Cancer Therapeutics and Metastasis Classifier Diagnostic Projects Show Significant Progress

REHOVOT, Israel, May 8 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leader in microRNA-based diagnostics and therapeutics,...


May 08, 2007, 01:00 ET Rosetta Genomics, a Leader in MicroRNA-based Diagnostics and Therapeutics Reports First Quarter 2007 Financial Results; Liver Cancer Therapeutics and Metastasis Classifier Diagnostic Projects Show Significant Progress

REHOVOT, Israel, May 8 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leader in microRNA-based diagnostics and therapeutics,...


May 03, 2007, 01:00 ET Rosetta Genomics Ltd. Announces the Appointment of J. Michael French to President of its U.S Subsidiary, Rosetta Genomics, Inc.

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today the appointment of J. Michael French as the new President of its...


May 01, 2007, 01:00 ET Rosetta Genomics First Quarter 2007 Financial Results Conference Call

REHOVOT, Israel and NEW BRUNSWICK, N.J., May 1 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG) announced that the company will...


May 01, 2007, 01:00 ET Rosetta Genomics Announces First Source for Clinical Validation of its Cancer of Unknown Primary (CUP) Diagnostic Test

REHOVOT, Israel and DETROIT, Michigan, May 1 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq:ROSG) announced today that it has signed an...


May 01, 2007, 01:00 ET Rosetta Genomics to Announce First Quarter 2007 Financial Results and Host Conference Call on Tuesday, May 8, 2007

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG) announced that the company will report first quarter 2007 financial results on...


Apr 23, 2007, 01:00 ET NYU Medical Center Partners With Rosetta Genomics to Develop a Line of Diagnostic Tools for Lung and Mesothelioma Cancers

REHOVOT, Israel and NEW YORK, New York, April 23 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today that it has...


Apr 20, 2007, 01:00 ET Rosetta Genomics Announces it has Presented Data on Advancements Made in the Company's Lead Assay Development Program for Cancer of Unknown Primary (CUP)

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), announced today that it has presented updated results on its lead diagnostic...


Sep 07, 2006, 01:00 ET Rosetta Genomics Ltd. Files for Initial Public Offering

REHOVOT, Israel, September 7 /PRNewswire/ -- Rosetta Genomics today announced that it has filed a registration statement with the Securities and...


Jul 27, 2006, 01:00 ET Rosetta Genomics and Max Planck Society Enter Microrna Licensing Agreement

NORTH BRUNSWICK, New Jersey, July 27 /PRNewswire/ -- - Deal Gives Rosetta Genomics Access to Potentially Hundreds of Human Proprietary...


May 24, 2006, 01:00 ET Rosetta Genomics Ltd. and U.S. Genomics Inc. Announce Collaboration Agreement To Develop a Non-Invasive MicroRNA-Based Early Detection Test For Lung Cancer

REHOVOT, Israel and WOBURN, Mass., May 24 /PRNewswire/ -- Rosetta Genomics Ltd. and U.S. Genomics Inc. announced today the signing of a...


Feb 22, 2006, 00:00 ET Isis Pharmaceuticals and Rosetta Genomics Announce Joint Research Collaboration to Develop Micro-RNA Related Therapies for the Treatment of Liver Cancer

CARLSBAD, Calif. and REHOVOT, Israel, Feb. 22 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Rosetta Genomics Ltd., a privately...


Sep 12, 2005, 01:00 ET Ambion and Rosetta Genomics Announce Licensing and Commercialization Deal To Advance microRNA Research

TENAFLY, N.J., Sept. 12 /PRNewswire/ -- Rosetta Genomics Ltd., a privately held biopharmaceutical company that develops microRNA-based...